Tokyo, July 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058629) titled 'General supplement intake test' on July 30.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - Sunsho Pharmaceutical Co., Ltd.
Condition:
Condition - Healthy volunteer
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Verification of whether taking supplements improves health checkup results
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Test foods A-1 (1 capsule/day), A-2 (4 tablets/day), A-3 (4 capsules/day), and B-1 (1 tablet/day) were taken continuously for 24 weeks.
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Healthy person
Key exclusion criteria - Those currently undergoing treatment for an illness (including taking medicines), those who need treatment for an illness, or those who are scheduled to undergo treatment in the future, and those who are deemed inappropriate by the principal investigator
Target Size - 418
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 06 Month 20 Day
Date of IRB - 2025 Year 06 Month 23 Day
Anticipated trial start date - 2025 Year 08 Month 01 Day
Last follow-up date - 2026 Year 05 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066570
Disclaimer: Curated by HT Syndication.
